Company Name or Ticker Symbol
Search for other Categories

Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

Select the Comparisons : Select the Ratio:                        

ATRA Quick Ratio for Trailing Twelve Months Period

(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
Y / Y Current Liabilities Growth 20.66 % 14.74 % -11.91 % -0.35 % 112.22 %
Y / Y Cash & cash equivalent Growth -27.95 % -26.3 % -24.66 % -20.22 % -16.79 %
Quick Ratio for Trailing Twelve Months Period 19.88 23.02 25.73 26.87 28.38
Total Ranking # 77 # 51 # 53 # 0 # 0
Seq. Current Liabilities Growth 43.86 % 47.1 % -19.33 % -29.32 % 36.8 %
Seq. Cash & cash equivalent Growth -7.68 % -5.96 % -9.72 % -8.08 % -5.57 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to jump in Current Liabilities in the III. Quarter to $17 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 19.88 below Atara Biotherapeutics, Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 2 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 3
Sector # 11
S&P 500 # 77

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
35.85 28.02 19.88
(June 30. 2016)   (Sep 30 2017)

You need to upgrade your Flash Player

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2017, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Regenxbio Inc.  37.89 
Lion Biotechnologies, Inc.  33.51 
Adverum Biotechnologies, Inc.  30.81 
Kubota Pharmaceutical Holdings Co Ltd  26.52 
Atara Biotherapeutics, Inc.  18.52 
Enzon Pharmaceuticals, Inc.  18.39 
Aclaris Therapeutics, Inc.  18.31 
Gtx Inc  18.25 
Crispr Therapeutics Ag  16.85 
Aerie Pharmaceuticals Inc  16.34 
Pulse Biosciences, Inc.  14.40 
Organovo Holdings, Inc.  13.81 
Neurocrine Biosciences Inc  13.80 
Wave Life Sciences Ltd.  12.60 
Edge Therapeutics, Inc.  12.42 
Acceleron Pharma Inc  12.17 
Cadus Corp  12.14 
Artemis Therapeutics, Inc.  12.10 
Fennec Pharmaceuticals Inc.  11.97 
La Jolla Pharmaceutical Co  11.62 
Hedgepath Pharmaceuticals, Inc.  11.48 
Alder Biopharmaceuticals Inc  11.35 
Mateon Therapeutics Inc  11.31 
Bluebird Bio, Inc.  10.55 
Syndax Pharmaceuticals Inc  10.51 
Brainstorm Cell Therapeutics Inc.  10.50 
Audentes Therapeutics, Inc.  10.39 
Spark Therapeutics, Inc.  10.10 
Cellular Biomedicine Group, Inc.  10.02 
Obalon Therapeutics Inc  9.88 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

NVFY's Profile

Stock Price

NVFY's Financials

NVFY's Expectations

Business Description


Charts & Quotes

NVFY's News


NVFY's Competitors

Customers & Markets

Economic Indicators

NVFY's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com